|
||
| |||||||
|
The Pharmaceutical CRM Outlook: Optimizing returns from operational and analytical CRM A new strategic management report from Reuters Business Insight The
new Reuters Business Insight report: ‘The Pharmaceutical CRM Outlook:
Optimizing returns from operational and analytical investment’ analyzes the
current operational and analytical CRM practises and outlines in detail the
future developments that will increase the return on investment (ROI) within
sales, marketing and customer fulfillment activities. Improve
your sales force effectiveness, maximize product usage and drive up your ROI
with the help of this latest report… Top three reasons why this is a 'must have' report this month: Secure
the most profitable customers and capitalize on CRM's potential to increase your
customer's propensity to purchase products or services at a lowered cost of
transaction. Reduce
set-up time and costs of CRM experimentation by learning from the industry
leaders' best practice such as Roche, AstraZeneca and Merck. Utilize
technology-based solutions to increase the ROI from physician detailing and
assess the viability of newer technologies, such as voice recognition and iTV. Order Today! Reuters Business Insight reports are published by Datamonitor, in association with Reuters. Reuters, the sphere logo and Reuters Business Insight are trade marks of the Reuters group of companies around the worldTo order these reports contact peter.barfoot@bioportfolio.com or telephone +44 1300 321501 or +1 415 680 2472 and a representative will get back to you. You can also order on line at: http://www.bioportfolio.com/cgi-bin/acatalog/search.html |
|
| ||||||||